+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Interventional Oncology Market - Global Forecast 2025-2030- Product Image
Interventional Oncology Market - Global Forecast 2025-2030- Product Image
Sale

Interventional Oncology Market - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 197 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 4905026
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Senior executives in healthcare and medical device sectors are witnessing a dynamic evolution within the interventional oncology market, where continuous technology innovation, clinical rigor, and regulatory changes are converging to reshape treatment pathways and strategic priorities.

Market Snapshot: Interventional Oncology Market Growth

The interventional oncology market grew from USD 2.55 billion in 2024 to USD 2.73 billion in 2025. It is expected to continue growing at a CAGR of 7.39%, reaching USD 3.92 billion by 2030. Market progress is supported by increased adoption of minimally invasive cancer treatments, improved reimbursement landscapes, and a shift toward value-focused care models. Stakeholders are benefiting from expanding therapy options and heightened interest in precision oncology supported by technological innovation.

Scope & Segmentation of the Interventional Oncology Market

  • Product Segments: Ablation devices, including cryoablation systems, high-intensity focused ultrasound, and laser systems; embolization devices, such as drug-eluting beads and microspheres; and supportive devices, featuring guidewires and introduction kits.
  • Cancer Types: Colorectal cancer, kidney cancer, liver cancer, lung cancer – each with tailored technologies and clinical approaches.
  • Key Technologies: Brachytherapy, image-guided radiotherapy, microwave ablation, radiofrequency ablation – enabling multimodal tumor management.
  • End-User Settings: Hospitals, ambulatory surgical centers, and cancer research institutes – each driving unique adoption patterns and service demands.
  • Regional Coverage: Americas (including the US, Canada, Brazil, Mexico, Argentina), Europe, Middle East & Africa (such as Germany, France, UK, UAE, South Africa, Russia, Italy, Saudi Arabia, Spain, and additional markets), and Asia-Pacific (including China, Japan, India, Australia, and other major economies).
  • Industry Players: Major contributors include Abbott Laboratories, Bayer AG, Boston Scientific Corporation, Medtronic PLC, Siemens Healthineers AG, and Terumo Corporation, along with a dynamic mix of innovators in device manufacturing and clinical service delivery.

Key Takeaways for Senior Decision-Makers

  • Minimally invasive approaches are enhancing precision in cancer care, enabling targeted therapies that reduce recovery time and improve patient quality of life.
  • Advances such as cryoablation, high-intensity ultrasound, and next-generation beads are increasing the range of treatable indications and supporting clinical workflow improvements.
  • Artificial intelligence, remote monitoring, and hybrid imaging suites are accelerating procedural accuracy and operational efficiency, supporting broader deployment of interventional oncology platforms.
  • Strategic partnerships between leading manufacturers, academic centers, and research institutes are accelerating technology validation and supporting adoption of novel treatment standards.
  • Healthcare providers are leveraging bundled service models and outcomes-based contracts to align purchases with clinical value, promoting evidence-driven procurement and sustained innovation.

Tariff Impact: Navigating Cost and Supply Chain Shifts

Recent United States tariff adjustments have influenced medical device supply chains and local cost structures, prompting hospitals and ambulatory surgical centers to refine sourcing strategies and strengthen vendor negotiations. This has led some manufacturers to diversify production locations and explore nearshoring, while providers place greater emphasis on cost control and value delivery across device portfolios. Resulting industry responses include collaborative regulatory streamlining to safeguard the pace of product innovation.

Methodology & Data Sources

The research approach blends qualitative and quantitative methodologies, incorporating structured interviews with key opinion leaders—including interventional radiologists, oncologists, and procurement specialists—alongside secondary analysis of peer-reviewed articles, regulatory records, and technology reports. Data validation is ensured through expert panel reviews, triangulation of primary and secondary insights, and close adherence to data privacy standards.

Why This Report Matters for Decision-Makers

  • Provides actionable insights to help leaders optimize investment strategies and address evolving demands in interventional oncology.
  • Supports technology selection, resource allocation, and partnership development with clear analyses of product, technology, and end-user dynamics.
  • Equips executives to navigate regulatory changes, supply chain fluctuations, and regional variations for robust market positioning.

Conclusion

The interventional oncology market is advancing through technology, partnerships, and regulatory adaptation. Stakeholders prepared to leverage data-driven strategy, next-generation tools, and collaborative research will be positioned for sustainable market success.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Growth of personalized drug-eluting microsphere therapies guided by genomic biomarkers for liver cancer treatment
5.2. Development of nanotechnology-based chemoembolic agents for targeted drug delivery and reduced systemic toxicity in liver tumors
5.3. Advancements in robotic-assisted microwave ablation systems enhancing procedural efficiency and lesion control in interventional oncology
5.4. Adoption of cryoablation techniques in minimally invasive treatment of prostate and renal tumors with enhanced safety profiles
5.5. Emergence of combined immunoembolization strategies leveraging checkpoint inhibitors to boost local and systemic tumor response
5.6. Integration of real-time imaging and AI-enabled navigation in catheter-based tumor embolization achieving unprecedented precision
5.7. Strategic partnerships between device manufacturers and pharma companies driving next-generation radioembolization product pipelines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Interventional Oncology Market, by Product
8.1. Introduction
8.2. Ablation Devices
8.2.1. Cryoablation Devices
8.2.2. High-Intensity Focused Ultrasound
8.2.3. Laser Systems
8.3. Embolization Devices
8.3.1. Drug-Eluting Beads
8.3.2. Microspheres
8.4. Supportive Devices
8.4.1. Guidewires
8.4.2. Introduction Kits
9. Interventional Oncology Market, by Cancer Type
9.1. Introduction
9.2. Colorectal Cancer
9.3. Kidney Cancer
9.4. Liver Cancer
9.5. Lung Cancer
10. Interventional Oncology Market, by Technology
10.1. Introduction
10.2. Brachytherapy
10.3. Image-Guided Radiotherapy
10.4. Microwave Ablation
10.5. Radiofrequency Ablation
11. Interventional Oncology Market, by End-User
11.1. Introduction
11.2. Ambulatory Surgical Centers
11.3. Cancer Research Institutes
11.4. Hospitals
12. Americas Interventional Oncology Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Interventional Oncology Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Interventional Oncology Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. Abbott Laboratories
15.3.2. ABK Biomedical Inc.
15.3.3. Accuray Incorporated
15.3.4. AngioDynamics, Inc.
15.3.5. Bayer AG
15.3.6. Boston Scientific Corporation
15.3.7. Cook Group Incorporated
15.3.8. Eckert & Ziegler BEBIG AG
15.3.9. Fujifilm Holdings Corporation
15.3.10. GE HealthCare Technologies Inc.
15.3.11. IceCure Medical Ltd.
15.3.12. Integer Holding Corporation
15.3.13. Johnson & Johnson Services, Inc.
15.3.14. Koninklijke Philips N.V.
15.3.15. Medtronic PLC
15.3.16. Merit Medical Systems, Inc.
15.3.17. Siemens Healthineers AG
15.3.18. Sirtex Medical Limited
15.3.19. Sonablate Corp
15.3.20. STARmed Co., Ltd.
15.3.21. Stryker Corporation
15.3.22. Surgnova Healthcare Technologies (Zhejiang) Co., Ltd.
15.3.23. Teleflex Incorporated
15.3.24. Terumo Corporation
15.3.25. Becton, Dickinson and Company
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. INTERVENTIONAL ONCOLOGY MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
FIGURE 6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 14. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 16. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. INTERVENTIONAL ONCOLOGY MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 22. INTERVENTIONAL ONCOLOGY MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 23. INTERVENTIONAL ONCOLOGY MARKET: RESEARCHAI
FIGURE 24. INTERVENTIONAL ONCOLOGY MARKET: RESEARCHSTATISTICS
FIGURE 25. INTERVENTIONAL ONCOLOGY MARKET: RESEARCHCONTACTS
FIGURE 26. INTERVENTIONAL ONCOLOGY MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. INTERVENTIONAL ONCOLOGY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CRYOABLATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CRYOABLATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HIGH-INTENSITY FOCUSED ULTRASOUND, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LASER SYSTEMS, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY DRUG-ELUTING BEADS, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY DRUG-ELUTING BEADS, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROSPHERES, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROSPHERES, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, BY REGION, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, BY REGION, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY GUIDEWIRES, BY REGION, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY INTRODUCTION KITS, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY INTRODUCTION KITS, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COLORECTAL CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY KIDNEY CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LIVER CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY LUNG CANCER, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY BRACHYTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY IMAGE-GUIDED RADIOTHERAPY, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY MICROWAVE ABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY RADIOFREQUENCY ABLATION, BY REGION, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER RESEARCH INSTITUTES, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2030 (USD MILLION)
TABLE 65. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 66. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 67. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 68. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 69. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 70. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 71. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 72. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 73. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 74. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 75. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 76. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 77. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 78. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 81. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 82. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 83. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 84. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 85. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 86. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 87. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 88. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 89. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 90. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 91. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 92. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 93. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 94. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 95. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 96. UNITED STATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 97. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 98. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 99. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 100. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 101. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 102. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 103. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 104. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 105. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 106. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 107. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 108. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 109. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 110. CANADA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 111. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 112. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 113. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 114. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 115. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 116. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 117. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 118. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 119. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 120. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 121. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 122. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 123. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 124. MEXICO INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 125. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 126. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 127. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 128. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 129. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 130. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 131. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 132. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 133. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 134. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 135. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 136. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 137. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 138. BRAZIL INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 139. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 140. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 141. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 142. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 143. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 144. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 145. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 146. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 147. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 148. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 149. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 150. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 151. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 152. ARGENTINA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 153. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 154. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 155. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 156. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 157. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 158. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 159. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 160. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 161. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 162. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 163. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 164. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 165. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 166. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 167. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 168. EUROPE, MIDDLE EAST & AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 169. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 170. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 171. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 172. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 173. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 174. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 175. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 176. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 177. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 178. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 179. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 180. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 181. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 182. UNITED KINGDOM INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 183. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 184. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 185. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 186. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 187. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 188. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 189. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 190. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 191. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 192. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 193. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 194. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 195. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 196. GERMANY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 197. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 198. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 199. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 200. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 201. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 202. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 203. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 204. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 205. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 206. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 207. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 208. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 209. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 210. FRANCE INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 211. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 212. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 213. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 214. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 215. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 216. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 217. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 218. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 219. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 220. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 221. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 222. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 223. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 224. RUSSIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 225. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 226. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 227. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 228. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 229. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 230. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 231. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 232. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 233. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 234. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 235. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 236. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 237. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 238. ITALY INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 239. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 240. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 241. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 242. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 243. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 244. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 245. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 246. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 247. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 248. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 249. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 250. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 251. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 252. SPAIN INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 253. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 254. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 255. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 256. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 257. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 258. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 259. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 260. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 261. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 262. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 263. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 264. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 265. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 266. UNITED ARAB EMIRATES INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 267. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 268. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 269. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 270. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 271. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 272. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 273. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 274. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 275. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 276. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 277. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 278. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 279. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 280. SAUDI ARABIA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 281. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 282. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 283. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 284. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 285. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 286. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 287. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 288. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 289. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 290. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 291. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 292. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 293. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 294. SOUTH AFRICA INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 295. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 296. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 297. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 298. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 299. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 300. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 301. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 302. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 303. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 304. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 305. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 306. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 307. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 308. DENMARK INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 309. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 310. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2025-2030 (USD MILLION)
TABLE 311. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2018-2024 (USD MILLION)
TABLE 312. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY ABLATION DEVICES, 2025-2030 (USD MILLION)
TABLE 313. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2018-2024 (USD MILLION)
TABLE 314. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY EMBOLIZATION DEVICES, 2025-2030 (USD MILLION)
TABLE 315. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2018-2024 (USD MILLION)
TABLE 316. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY SUPPORTIVE DEVICES, 2025-2030 (USD MILLION)
TABLE 317. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2018-2024 (USD MILLION)
TABLE 318. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY CANCER TYPE, 2025-2030 (USD MILLION)
TABLE 319. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
TABLE 320. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY TECHNOLOGY, 2025-2030 (USD MILLION)
TABLE 321. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2018-2024 (USD MILLION)
TABLE 322. NETHERLANDS INTERVENTIONAL ONCOLOGY MARKET SIZE, BY END-USER, 2025-2030 (USD MILLION)
TABLE 323. QATAR INTERVENTIONAL ONCOLOGY MARKET SIZE, BY PRODUCT, 2018-2024 (USD MILLION)
TABLE 324. QATAR I

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott Laboratories
  • ABK Biomedical Inc.
  • Accuray Incorporated
  • AngioDynamics, Inc.
  • Bayer AG
  • Boston Scientific Corporation
  • Cook Group Incorporated
  • Eckert & Ziegler BEBIG AG
  • Fujifilm Holdings Corporation
  • GE HealthCare Technologies Inc.
  • IceCure Medical Ltd.
  • Integer Holding Corporation
  • Johnson & Johnson Services, Inc.
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Merit Medical Systems, Inc.
  • Siemens Healthineers AG
  • Sirtex Medical Limited
  • Sonablate Corp
  • STARmed Co., Ltd.
  • Stryker Corporation
  • Surgnova Healthcare Technologies (Zhejiang) Co., Ltd.
  • Teleflex Incorporated
  • Terumo Corporation
  • Becton, Dickinson and Company

Table Information

Report AttributeDetails
No. of Pages197
PublishedAugust 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 2.73 Billion
Forecasted Market Value ( USD ) by 2030 $ 3.92 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Interventional Oncology Market by Devices & Consumables (RF, Microwave, Cryoablation. Embolization), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung), End User (Hospital, Specialty Clinic) - Global Forecast to 2029 - Product Image

Interventional Oncology Market by Devices & Consumables (RF, Microwave, Cryoablation. Embolization), Procedures (Thermal Ablation, Non-Thermal Ablation, TACE, TARE, TAE), Cancer (Liver, Lung), End User (Hospital, Specialty Clinic) - Global Forecast to 2029

  • Report
  • 456 Pages
  • Global
From
Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Applications (Liver Cancer), By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Interventional Oncology Market Size, Share & Trends Analysis Report By Technique (Ablation Therapies, Embolization Therapies), By Procedure (Tumor Ablation, Tumor Biopsy), By Applications (Liver Cancer), By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 210 Pages
  • Global
From
Interventional Oncology Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type - Product Image

Interventional Oncology Global Market Insights 2025, Analysis and Forecast to 2030, by Market Participants, Regions, Technology, Application, Product Type

  • Report
  • 124 Pages
  • Global
From
Interventional Oncology Devices - Global Strategic Business Report - Product Image

Interventional Oncology Devices - Global Strategic Business Report

  • Report
  • 282 Pages
  • Global
From
Interventional Oncology Devices Market Report 2025 - Product Image

Interventional Oncology Devices Market Report 2025

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.